The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
Abstract There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
XMLink
2020-07-01
|
| Seri Bilgileri: | Clinical Hypertension |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s40885-020-00147-x |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|